• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX HOLLOW FIBER OXYGENATOR/ARTERIAL FILTER; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX HOLLOW FIBER OXYGENATOR/ARTERIAL FILTER; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number 1ZZ*FX05REA
Device Problem Coagulation in Device or Device Ingredient (1096)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/01/2020
Event Type  malfunction  
Manufacturer Narrative
Lot numbers: 190705, 190729, or 191023.Expiration date - lot.:190705 june 30, 2022; lot.:190729 june 30, 2022; lot.:191023; september 30, 2022.Udi: not required for product code.Implanted date: device was not implanted; explanted date: device was not explanted; occupation-ccp.Device manufacturer date - lot.: 190705 july 5, 2019; lot.:190729 july 29, 2019; lot.:191023 october 23, 2019.The actual device was not returned, therefore, an evaluation of the actual device was unable to be conducted.A picture was provided by the user facility, and revealed a formation of substance that seemed to be white clots on the oxygenator filter surface.The result of the performance test (the pressure drop measured during the circulation of bovine blood at hct 35% and temp.37° c) conducted before the shipment from the factory for the same fiber lot product as the actual product was reviewed, and it was confirmed that the performance value was confirmed to be within the control criteria.A review of the device history record and product-release judgement record of the involved product code/lot# 190705 or 190729 or 191023 combinations was conducted with no findings.Ifu states: do not reduce heparin during circulation.Otherwise, blood clotting might occur.Adequate heparinization of the blood is required to prevent it from clotting in the system.With no return of the actual device, the exact cause of the reported event cannot be definitively determined based on the available information.(b)(4).
 
Event Description
The user facility reported that the involved capiox device was used during cardiopulmonary bypass.Fibrin was pulsating on the fiber bundle.During cpb, ccp noticed what looked like to be fibrin pulsating on the fiber bundle.The device was not changed out, the surgery was completed successfully.There was no patient injury, and there was no blood loss.The approximate time of occurrence was 9:01am.The event did not delay the procedure.
 
Event Description
Additional information was received 06oct2020.The patient had no prior interventions.8:56 pre-cpb act = 431.On cpb: 9:01.9:14 act = 581.9:43 act = 999 (this is an unmeasurable value so the value could have been mid 400 or lower).9:58 act = 424.Off cpb at 10:07.About 45 minutes into case noticed clot.Cooled to 28 degrees.Hematologic workups are not done routinely on their patients.There were no unusual pre-op meds given to the patient.The patient was not on pre-op anticoagulants.They do not rap.They often see act values of 999 on numerous cases and they think this is an acceptable value.Their protocol for a target act values is 400 seconds.
 
Manufacturer Narrative
This report is being submitted as follow up no.1 to provide a correction.Additional information was inadvertently not provided in the initial report.Therefore, section b5 has been updated to provide the additional information received.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX HOLLOW FIBER OXYGENATOR/ARTERIAL FILTER
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
MDR Report Key10704529
MDR Text Key214617064
Report Number9681834-2020-00215
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
PMA/PMN Number
K071572
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 10/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/20/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number1ZZ*FX05REA
Device Catalogue NumberZZ*FX05REA
Was Device Available for Evaluation? No
Date Manufacturer Received10/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-